Registration Dossier

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

Data waiving:
In accordance with column 2 of REACH Annex X, the study is not required since the substance is not classified as mutagen and there is no evidence from the repeated dose study that the substance is able to induce hyperplasia and/or pre-neoplastic lesions.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Data waiving:

The study is not required since the substance is not classified as mutagen and there is no evidence from the repeated dose study that the substance is able to induce hyperplasia and/or pre-neoplastic lesions.


Justification for selection of carcinogenicity via oral route endpoint:
In accordance with column 2 of REACH Annex X, the study is not required since the substance is not classified as mutagen and there is no evidence from the repeated dose study that the substance is able to induce hyperplasia and/or pre-neoplastic lesions.

Justification for classification or non-classification